mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.001 |
mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
-0.48 |
0.001 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.001 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.002 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.002 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.002 |